Specialty Medical Chemicals
- Submitted by: BSPEN
- Views: 895
- Category: Politics: Economics
- Date Submitted: 02/13/2011 08:01 AM
- Pages: 6
- Report this Essay
Specialty Medical Chemicals
Case Analysis
Special Medical Chemicals is company that has uniquely cornered a niche market in the pharmaceutical industry. The company experienced rapid growth, but has now plateaued. Carl Burke, the newly elected CEO, has been given the task of reigniting the growth engine of the company without undoing the accomplishments of his predecessor. For the first few months, Carl spends time in the field trying to understand the business, its people, and how the organization works. After an unsuccessful attempt to create a “Leadership Team” similar to his former company, Carl decides to hire an outside consultant, Laura Burke, to independently assess the functionality of his management team. Laura provides insight as to the issues of the management team and Carl’s impact on that team.
Carl realizes that the company has many strengths. Since its conception, the company has created hundreds of patents for specialty chemicals that allow other drugs to be taken more effectively and conveniently. SMC maintains a strong client base by helping them develop new compounds for their new products. Carl’s biggest concern is how the company is failing to grow within the industry, specifically within biotech and generic drug companies. Other weaknesses lie within the organizational culture where departments are entrenched into their own silos. For example, product development is not responsive to new business. Departments such as sales and manufacturing function at a high level, while administration (specifically customer service and personnel) is vastly underperforming.
Carl brings to the table experiences in new product development and senior team management. The biggest challenge that Carl faces is to create a cross-functional team where departments are collectively working towards the success of the company. If the team is leveraged correctly, they could accomplish the goal of igniting new growth in the biotech and generic...
Case Analysis
Special Medical Chemicals is company that has uniquely cornered a niche market in the pharmaceutical industry. The company experienced rapid growth, but has now plateaued. Carl Burke, the newly elected CEO, has been given the task of reigniting the growth engine of the company without undoing the accomplishments of his predecessor. For the first few months, Carl spends time in the field trying to understand the business, its people, and how the organization works. After an unsuccessful attempt to create a “Leadership Team” similar to his former company, Carl decides to hire an outside consultant, Laura Burke, to independently assess the functionality of his management team. Laura provides insight as to the issues of the management team and Carl’s impact on that team.
Carl realizes that the company has many strengths. Since its conception, the company has created hundreds of patents for specialty chemicals that allow other drugs to be taken more effectively and conveniently. SMC maintains a strong client base by helping them develop new compounds for their new products. Carl’s biggest concern is how the company is failing to grow within the industry, specifically within biotech and generic drug companies. Other weaknesses lie within the organizational culture where departments are entrenched into their own silos. For example, product development is not responsive to new business. Departments such as sales and manufacturing function at a high level, while administration (specifically customer service and personnel) is vastly underperforming.
Carl brings to the table experiences in new product development and senior team management. The biggest challenge that Carl faces is to create a cross-functional team where departments are collectively working towards the success of the company. If the team is leveraged correctly, they could accomplish the goal of igniting new growth in the biotech and generic...